Vendor, Deerfield, IL
Takeda Vaccines Inc.
UEI XL5XEUMAJDQ8, CAGE 1NTS0
1 award and -$7,416,267 obligated between May 9, 2024 and September 26, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$7,416,267 |
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | -$7,416,267 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100201600015CDefinitive Contract, May 9, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | This Administrative Modification Is to Extend the Period of Performance at No Cost to the Government for Option Period 5 and Option 6. the ANAICS 325413, PSC AN13 | -$7,416,267 |
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 2 across 1 awards